Global Human Vaccines Market Size, Trends, Opportunities and Growth Potential
- DPI3275987
- 310 Pages
- October 2019
- Healthcare
The prominent factors that are expected to contribute to the growth of the global human vaccines market during the forecast period:
• Increased Disease Awareness
• Approval/launches of the New Vaccines
• Rising focus on immunization programs
• Increasing government support for the vaccine development
Highlighted with 35 tables and 140 figures, this 310-page report “Global Human Vaccines Market Size, Trends, Opportunities and Growth Potential” provides a comprehensive analysis of the fast-evolving, high-growth global human vaccines market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the global human vaccines market. The report provides historical market data for 2015 – 2018, and forecasts from 2019 till 2025.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides in-depth analysis, information and revenue according to segments such as disease indications, end users, leading vaccines, and companies from 2015 to 2018 and forecasts to 2025. A comprehensive analysis has been done on market share with percentage of all the segments.
Key trends in terms of collaboration, partnerships, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also examines the main market growth driving and restraining forces and also gives an all-round future outlook through 2025.
The report concludes with the profiles of the key players in the global human vaccines market. The key players are evaluated on various parameters such as business overview, vaccines portfolio, promising vaccines in the clinical development, vaccines revenue analysis and recent development.
Other emerging players are making novel technology-based vaccines which are likely to affect the market share during the forecast period. The emerging players are evaluated on various parameters such as business overview, promising vaccines in the clinical development with phase, platform technology and diseases which are seeing vaccines development activity such as infectious diseases, non-infectious diseases, emerging pathogens and recent development.
Key Topics Covered in the Report:
• The Market Size of the Global Human Vaccines Market
• The Market Size of the Global Pediatric Vaccines Market
• The Market Size of the Global Adult Vaccines Market
• The Market Size of the 42 Leading Vaccines
• The Market Size of the Pneumococcal Disease, Diphtheria, Tetanus and Pertussis (DTP), Influenza, Human Papilloma Virus (HPV), Meningococcal, Hepatitis, Measles, Mumps, and Rubella (MMR), Rotavirus, Varicella.
• Thoroughly Evaluates Market Share of the Segments such as Disease Indications, End Users, Leading Vaccines, and Companies
• Investigates the Key Growth Drivers and Restraints of the Global Human Vaccines Market
• Provides Key Trends with Respect to Collaboration, Partnerships, Merger & Acquisition, Distribution, Exclusive and Licensing Agreement
• A Comprehensive List of the Key Players Along with the Analysis of their Current Vaccines Portfolios, Promising Vaccines in the Clinical Development, Sales Value Analysis, and Recent Development
• An Insightful Analysis of the Emerging Players Along with the Analysis of their Promising Vaccines in the Clinical Development, Platform Technology, and Recent Development
Detailed Segmentation:
Global Human Vaccines Market, By Disease Indication
• Influenza
• Meningococcal
• Hepatitis
• Rotavirus
• Varicella
• Pneumococcal Disease
• Diphtheria, Tetanus and Pertussis (DTP)
• Measles, Mumps, and Rubella (MMR)
• Human Papilloma Virus (HPV)
Global Human Vaccines Market, By End User
• Pediatric Vaccines
• Adult Vaccines
Global Human Vaccines Market, By Leading Vaccines
• Prevnar / Prevnar 13
• Gardasil / Gardasil 9
• Vaxigrip
• Fluzone
• Flublok
• Varivax
• Menactra
• Proquad
• Pneumovax 23
• Fluarix/FluLaval
• Havrix/Twinrix/Engerix–B
• Priorix, Priorix Tetra, Varilrix
• M–M–R II
• Adacel
• Boostrix
• Bexsero
• Menveo
• Cervarix
• Trumenba
• Shingrix
• Pentacel, Pentaxim, Imovax, Hexaxim
• Rotateq
• Zostavax
• Rotarix
• Synflorix
• Pediarix, Infanrix
• Ticovac
• Biken Ha
• Tetrabik
• Mearubik
• Varicella (MTP)
• Jebik V
• Flumist/Fluenz
• Bio Thrax
• Dukoral
• Ixiaro
• In Live
• HeaLive
• BiLive
• Anflu
• EasySix
• Imvamune
Global Human Vaccines Market, By Key Players
• Sanofi Pasteur
• GlaxoSmithKline (GSK)
• Merck
• Pfizer
• AstraZeneca
• Mitsubishi Tanabe Pharma
• Emergent Biosolutions
• Astellas Pharma Inc.
• Valneva
• Seqirus
• Bavarian Nordic
• Sinovac
• Panacea Biotec
• Bharat Biotech
• Serum Institute of India
• Biological E. Limited
Global Human Vaccines Market, By Emerging Players
• Vaccitech
• Janssen (Johnson & Johnson)
• Novavax
• VBI Vaccines
• GeoVax
• Moderna Inc
• Biondvax
• Integrated Biotherapeutics Inc
• GeneOne Life Science
• Profectus BioSciences
• Pneumagen
• Themis Bioscience
• Xeme Biopharma Inc
• Altimmune
• Pfenex Inc
• Northwest Biotherapeutics
• OncBioMune Pharmaceuticals
The Report Helps Answer the Following Questions:
• What is the current size of the overall global human vaccines market? How much will this market be worth from 2019 to 2025?
• What are the market shares of the leading segments of the global human vaccines market in 2018?
• What are the main segments within the overall human vaccines market? How much will each of these segments be worth for the period 2015 to 2025?
• What are the main drivers and restraints in the global human vaccines market?
• What are the leading vaccines? What are their revenue potentials to 2025?
• What are the major deals happenings in the global vaccines market?
• Who are the leading companies and what are their activities, revenue, recent developments and prospects?
• What are some of the most prominent human vaccines currently in development? What are their activities, platform technology and recent developments?
• What are new diseases areas which the vaccines companies are exploring?
2. Global Vaccines Market Size & Forecast (2015 – 2025)
3. Market Share Analysis of Global Vaccines Market (%)
3.1 Global Vaccines Market Share, By Disease
3.2 Global Vaccines Market Share, By End User
3.3 Global Vaccines Market Share, By Leading Vaccine
3.4 Global Vaccines Market Share, By Company
4. Global Vaccines Market – Key Market Dynamics
4.1 Key Market Drivers
4.2 Key Market Inhibitors
5. Global Vaccines Market, By Disease
5.1 Pneumococcal Disease
5.2 Diphtheria, Tetanus and Pertussis (DTP)
5.3 Influenza
5.4 Human Papilloma Virus (HPV)
5.5 Meningococcal
5.6 Hepatitis
5.7 Measles, Mumps, and Rubella (MMR)
5.8 Rotavirus
5.9 Varicella
5.10 Other Diseases
6. Global Vaccines Market, By End User
6.1 Pediatric Vaccines
6.2 Adult Vaccines
7. Global Vaccines Market, By Leading Vaccine
7.1 Prevnar / Prevnar 13
7.2 Gardasil / Gardasil 9
7.3 Vaxigrip
7.4 Fluzone
7.5 Flublok
7.6 Varivax
7.7 Menactra
7.8 Proquad
7.9 Pneumovax 23
7.10 Fluarix/FluLaval
7.11 Havrix/Twinrix/Engerix–B
7.12 Priorix, Priorix Tetra, Varilrix
7.13 M–M–R II
7.14 Adacel
7.15 Boostrix
7.16 Bexsero
7.17 Menveo
7.18 Cervarix
7.19 Trumenba
7.20 Shingrix
7.21 Pentacel, Pentaxim, Imovax, Hexaxim
7.22 Rotateq
7.23 Zostavax
7.24 Rotarix
7.25 Synflorix
7.26 Pediarix,Infanrix
7.27 Ticovac
7.28 Biken Ha
7.29 Tetrabik
7.30 Mearubik
7.31 Varicella (MTP)
7.32 Jebik V
7.33 Flumist/Fluenz
7.34 BioThrax
7.35 Dukoral
7.36 Ixiaro
7.37 InLive
7.38 HeaLive
7.39 BiLive
7.40 Anflu
7.41 EasySix
7.42 Imvamune
7.43 Other Vaccines
8. Major Deals and Agreement Happenings in the Global Vaccines Market
8.1 Merger & Acquisitions
8.2 Collaboration Deal
8.3 Licensing Agreement
8.4 Exclusive Agreement
8.5 Distribution Agreement
8.6 Partnerships
9. Key Players in the Global Vaccines Market
9.1 Sanofi Pasteur
9.1.1 Business Overview
9.1.2 Vaccines Portfolio
9.1.3 Vaccines Market Value Analysis & Forecast
9.1.4 Promising Vaccines in the Clinical Development
9.1.5 Recent Development
9.2 GlaxoSmithKline (GSK)
9.2.1 Business Overview
9.2.2 Vaccines Portfolio
9.2.3 Vaccines Market Value Analysis & Forecast
9.2.4 Promising Vaccines in the Clinical Development
9.2.5 Recent Development
9.3 Merck
9.3.1 Business Overview
9.3.2 Vaccines Portfolio
9.3.3 Vaccines Market Value Analysis & Forecast
9.3.4 Promising Vaccines in the Clinical Development
9.3.5 Recent Development
9.4 Pfizer
9.4.1 Business Overview
9.4.2 Vaccines Portfolio
9.4.3 Vaccines Market Value Analysis & Forecast
9.4.4 Promising Vaccines in the Clinical Development
9.4.5 Recent Development
9.5 AstraZeneca
9.5.1 Business Overview
9.5.2 Vaccines Portfolio
9.5.3 Vaccines Market Value Analysis & Forecast
9.5.4 Recent Development
9.6 Mitsubishi Tanabe Pharma
9.6.1 Business Overview
9.6.2 Vaccines Portfolio
9.6.3 Vaccine Market Value Analysis & Forecast
9.6.4 Promising Vaccines in the Clinical Development
9.6.5 Recent Development
9.7 Emergent BioSolutions
9.7.1 Business Overview
9.7.2 Vaccines Portfolio
9.7.3 Vaccine Market Value Analysis & Forecast
9.7.4 Promising Vaccines in the Clinical Development
9.7.5 Recent Development
9.8 Astlellas Pharma Inc
9.8.1 Business Overview
9.8.2 Vaccines Portfolio
9.8.3 Vaccines Market Value Analysis & Forecast
9.8.4 Recent Development
9.9 Valneva
9.9.1 Business Overview
9.9.2 Vaccines Portfolio
9.9.3 Vaccines Market Value Analysis & Forecast
9.9.4 Promising Vaccines in the Clinical Development
9.9.5 Recent Development
9.10 Seqirus
9.10.1 Business Overview
9.10.2 Vaccines Portfolio
9.10.3 Vaccine Market Value Analysis & Forecast
9.10.4 Promising Vaccines in the Clinical Development
9.10.5 Recent Development
9.11 Bavarian Nordic
9.11.1 Business Overview
9.11.2 Vaccines Portfolio
9.11.3 Vaccine Market Value Analysis & Forecast
9.11.4 Promising Vaccines in the Clinical Development
9.11.5 Recent Development
9.12 Sinovac
9.12.1 Business Overview
9.12.2 Vaccines Portfolio
9.12.3 Vaccine Market Value Analysis & Forecast
9.12.4 Promising Vaccines in the Clinical Development
9.12.5 Recent Development
9.13 Panacea Biotec
9.13.1 Business Overview
9.13.2 Vaccines Portfolio
9.13.3 Vaccine Market Value Analysis & Forecast
9.13.4 Promising Vaccines in the Clinical Development
9.13.5 Recent Development
9.14 Bharat Biotech
9.14.1 Business Overview
9.14.2 Vaccines Portfolio
9.14.3 Promising Vaccines in the Clinical Development
9.14.4 Recent Development
9.15 Serum Institute of India
9.15.1 Business Overview
9.15.2 Vaccines Portfolio
9.15.3 Promising Vaccines in Clinical Development
9.15.4 Recent Development
9.16 Biological E. Limited
9.16.1 Business Overview
9.16.2 Vaccines Portfolio
9.16.3 Promising Vaccines in Clinical Development
9.16.4 Recent Development
10. Emerging Players in the Global Vaccines Market
10.1 Vaccitech
10.1.1 Business Overview
10.1.2 Promising Vaccines in the Clinical Development
10.1.3 Recent Development
10.2 Janssen (Johnson& Johnson)
10.2.1 Business Overview
10.2.2 Promising Vaccines in the Clinical Development
10.2.3 Recent Development
10.3 Novavax
10.3.1 Business Overview
10.3.2 Promising Vaccines in the Clinical Development
10.3.3 Recent Development
10.4 VBI Vaccines
10.4.1 Business Overview
10.4.2 Promising Vaccines in the Clinical Development
10.4.3 Recent Development
10.5 GeoVax
10.5.1 Business Overview
10.5.2 Promising Vaccines in the Clinical Development
10.5.3 Recent Development
10.6 Moderna Inc
10.6.1 Business Overview
10.6.2 Promising Vaccines in the Clinical Development
10.6.3 Recent Development
10.7 Biondvax
10.7.1 Business Overview
10.7.2 Promising Vaccines in the Clinical Development
10.7.3 Recent Development
10.8 Integrated Biotherapeutics Inc
10.8.1 Business Overview
10.8.2 Promising Vaccines in the Clinical Development
10.8.3 Recent Development
10.9 GeneOne Life Science
10.9.1 Business Overview
10.9.2 Promising Vaccines in the Clinical Development
10.9.3 Recent Development
10.10 Profectus BioSciences
10.10.1 Business Overview
10.10.2 Promising Vaccines in the Clinical Development
10.10.3 Recent Development
10.11 Pneumagen
10.11.1 Business Overview
10.11.2 Promising Vaccines in the Clinical Development
10.11.3 Recent Development
10.12 Themis Bioscience
10.12.1 Business Overview
10.12.2 Promising Vaccines in the Clinical Development
10.12.3 Recent Development
10.13 Xeme Biopharma Inc
10.13.1 Business Overview
10.13.2 Promising Vaccines in the Clinical Development
10.13.3 Recent Development
10.14 Altimmune
10.14.1 Business Overview
10.14.2 Promising Vaccines in the Clinical Development
10.14.3 Recent Development
10.15 Pfenex Inc
10.15.1 Business Overview
10.15.2 Promising Vaccines in the Clinical Development
10.15.3 Recent Development
10.16 Northwest Biotherapeutics
10.16.1 Business Overview
10.16.2 Promising Vaccines in the Clinical Development
10.16.3 Recent Development
10.17 OncBioMune Pharmaceuticals
10.17.1 Business Overview
10.17.2 Promising Vaccines in the Clinical Development
10.17.3 Recent Development
Table 9–2: Collaboration Deal in the Global Vaccines Market
Table 9–3: Licensing Agreement in the Global Vaccines Market
Table 9–4: Exclusive Agreement in the Global Vaccines Market
Table 9–5: Distribution Agreement in the Global Vaccines Market
Table 9–6: Partnerships in the Global Vaccines Market
Table 10–1: Sanofi Promising Vaccines in the Clinical Development
Table 10–2: GSK Promising Vaccines in the Clinical Development
Table 10–3: Merck Promising Vaccines in the Clinical Development
Table 10–4: Pfizer Promising Vaccines in the Clinical Development
Table 10–5: Mitsubishi Tanabe Pharma Promising Vaccines in the Clinical Development
Table 10–6: Emergent Biosolutions Promising Vaccines in the Clinical Development
Table 10–7: Valneva Promising Vaccines in the Clinical Development
Table 10–8: Seqirus Promising Vaccines in the Clinical Development
Table 10–9: Bavarian Nordic Promising Vaccines in the Clinical Development
Table 10–10: Sinovac Promising Vaccines in the Clinical Development
Table 10–11: Panacea Biotec Promising Vaccines in the Clinical Development
Table 10–12: Bharat Biotech Promising Vaccines in the Clinical Development
Table 11–1: Vaccitech Promising Vaccines in the Clinical Development
Table 11–2: Janssen Promising Vaccines in the Clinical Development
Table 11–3: Novavax Promising Vaccines in the Clinical Development
Table 11–4: VBI Vaccines Promising Vaccines in the Clinical Development
Table 11–5: GeoVax Promising Vaccines in the Clinical Development
Table 11–6: Moderna Promising Vaccines in the Clinical Development
Table 11–7: Biondvax Promising Vaccines in the Clinical Development
Table 11–8: Integrated Biotherapeutics Promising Vaccines in the Clinical Development
Table 11–9: GeneOne Life Science Promising Vaccines in the Clinical Development
Table 11–10: Profectus BioSciences Promising Vaccines in the Clinical Development
Table 11–11: Pneumagen Promising Vaccines in the Clinical Development
Table 11–12: Themis Bioscience Promising Vaccines in the Clinical Development
Table 11–13: Xeme Biopharma Promising Vaccines in the Clinical Development
Table 11–14: Altimmune Vaccines Promising Vaccines in the Clinical Development
Table 11–15: Pfenex Inc Promising Vaccines in the Clinical Development
Table 11–16: Northwest Biotherapeutics Promising Vaccines in the Clinical Development
Table 11–17: OncoBioMune Pharmaceuticals Promising Vaccines in the Clinical Development
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
